Literature DB >> 31154392

RSPO2 abnormal transcripts result from read-through in liver tumours with high ß-catenin activation and CTNNB1 mutations.

Quentin Bayard1,2, Jean-Charles Nault1,2,3, Jessica Zucman-Rossi1,2,4.   

Abstract

Entities:  

Keywords:  hepatocellular carcinoma

Mesh：

Substances：

Year:  2019        PMID： 31154392     DOI： 10.1136/gutjnl-2019-319089

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  2 in total

1.  RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis.

Authors:  Zhiying Yue; Xin Niu; Zengjin Yuan; Qin Qin; Wenhao Jiang; Liang He; Jingduo Gao; Yi Ding; Yanxi Liu; Ziwei Xu; Zhenxi Li; Zhengfeng Yang; Rong Li; Xiwen Xue; Yankun Gao; Fei Yue; Xiang H-F Zhang; Guohong Hu; Yi Wang; Yi Li; Geng Chen; Stefan Siwko; Alison Gartland; Ning Wang; Jianru Xiao; Mingyao Liu; Jian Luo
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 19.456

2.  miR-497-5p-RSPO2 axis inhibits cell growth and metastasis in glioblastoma.

Authors:  Kun Chen; Zheng Wang; Qi-Bei Zong; Meng-Ying Zhou; Qing-Fa Chen
Journal:  J Cancer       Date:  2022-01-24       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.